Other mutations detected in ganglioglioma by comprehensive molecular methods include a novel in-frame insertion at BRAF R506 in the β3-αC loop of the kinase domain, a CDC42BPB-BRAF fusion, KRAS Q61K mutations, an ERC2-RAF1 fusion, a germline NF1 mutation, and FGFR1/2 alterations [34]. The gene discussed is BRAF; the disease is ganglioglioma.